Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I think today's decline is a combination of Pfizer's news and traders taking profit after the stock ran up 100% in one week. Pfizer's competitors such as Merck and Moderna are also down big.

Some said B will get EUA after Phase 2 result. If Pfizer needs data for 1219 patients (Phase 2/3, 3000 planned patients) before applying for EUA, what makes you guys think IPIX can get EUA with 120 patients (Phase 2)?

The primary analysis of the interim data set evaluated data from 1219 adults who were enrolled by September 29, 2021. At the time of the decision to stop recruiting patients, enrollment was at 70% of the 3,000 planned patients from clinical trial sites across North and South America, Europe, Africa, and Asia, with 45% of patients located in the United States. Enrolled individuals had a laboratory-confirmed diagnosis of SARS-CoV-2 infection within a five-day period with mild to moderate symptoms and were required to have at least one characteristic or underlying medical condition associated with an increased risk of developing severe illness from COVID-19. Each patient was randomized (1:1) to receive PAXLOVID™ or placebo orally every 12 hours for five days.

https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate

Orchestrated take down of the most obvious manner.